| 9.2 |
27.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 6.3 |
19.0 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 3.6 |
10.9 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 3.5 |
21.0 |
GO:0032796 |
uropod organization(GO:0032796) |
| 2.5 |
10.0 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 2.0 |
8.0 |
GO:0002371 |
dendritic cell cytokine production(GO:0002371) |
| 2.0 |
5.9 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 1.7 |
5.2 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 1.6 |
4.8 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 1.5 |
7.6 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.4 |
4.3 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 1.4 |
4.3 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.3 |
3.9 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 1.3 |
7.8 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.3 |
6.3 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 1.2 |
5.0 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.2 |
3.7 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 1.2 |
6.0 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.2 |
4.6 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.2 |
4.6 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 1.1 |
4.5 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.1 |
1.1 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 1.1 |
6.3 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 1.0 |
11.2 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 1.0 |
6.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.0 |
4.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.0 |
2.9 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 1.0 |
2.9 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 1.0 |
2.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.9 |
3.8 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.9 |
4.7 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.9 |
0.9 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.9 |
8.2 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.9 |
1.8 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.9 |
2.7 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.9 |
3.6 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.9 |
9.8 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.9 |
6.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.9 |
3.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.9 |
2.6 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.9 |
0.9 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.9 |
4.3 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.9 |
3.4 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.8 |
2.5 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.8 |
0.8 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.8 |
2.5 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.8 |
3.3 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.8 |
3.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.8 |
2.4 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.8 |
2.4 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.8 |
2.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.8 |
5.6 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.8 |
3.1 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.8 |
11.7 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.8 |
2.3 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.8 |
7.7 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.8 |
2.3 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.8 |
2.3 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.8 |
3.0 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.8 |
3.0 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.8 |
0.8 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.7 |
4.5 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.7 |
2.2 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.7 |
2.9 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.7 |
5.7 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.7 |
14.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.7 |
9.2 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.7 |
0.7 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.7 |
2.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.7 |
0.7 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.7 |
5.5 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.7 |
2.0 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 |
1.3 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.7 |
2.0 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.7 |
2.0 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.7 |
2.0 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.6 |
1.3 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.6 |
2.6 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.6 |
0.6 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.6 |
0.6 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.6 |
1.2 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.6 |
4.9 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.6 |
2.4 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.6 |
1.8 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.6 |
8.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.6 |
4.7 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.6 |
0.6 |
GO:0032632 |
interleukin-3 production(GO:0032632) |
| 0.6 |
1.8 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.6 |
1.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.6 |
1.2 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.6 |
3.5 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.6 |
3.5 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.6 |
3.5 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.6 |
4.6 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.6 |
1.1 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.6 |
1.7 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.6 |
1.7 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.6 |
0.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.6 |
3.9 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.6 |
1.7 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.5 |
3.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.5 |
0.5 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 0.5 |
1.6 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.5 |
2.6 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.5 |
0.5 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.5 |
2.6 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.5 |
3.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.5 |
2.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.5 |
1.0 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 |
1.6 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.5 |
2.1 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.5 |
13.4 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.5 |
1.5 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.5 |
5.6 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.5 |
2.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.5 |
2.5 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.5 |
7.5 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.5 |
2.0 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.5 |
0.5 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.5 |
1.5 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.5 |
0.5 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.5 |
2.0 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 0.5 |
1.0 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.5 |
1.0 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.5 |
4.3 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.5 |
3.8 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.5 |
0.5 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.5 |
4.3 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.5 |
0.9 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.5 |
0.9 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.5 |
1.4 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.5 |
3.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.5 |
1.4 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.5 |
5.5 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.5 |
2.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.5 |
1.8 |
GO:0072186 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.4 |
1.8 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.4 |
2.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
0.9 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.4 |
0.9 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.4 |
0.9 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.4 |
1.3 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.4 |
5.3 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.4 |
1.3 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.4 |
7.0 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.4 |
3.9 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.4 |
4.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.4 |
0.9 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 |
2.6 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.4 |
0.9 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.4 |
1.3 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.4 |
2.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.4 |
3.8 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.4 |
4.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 |
2.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.4 |
0.4 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.4 |
1.6 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.4 |
1.6 |
GO:0042662 |
negative regulation of mesodermal cell fate specification(GO:0042662) |
| 0.4 |
1.2 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.4 |
2.0 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.4 |
1.6 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.4 |
2.0 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.4 |
1.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.4 |
2.0 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.4 |
1.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.4 |
1.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.4 |
0.8 |
GO:0032763 |
regulation of mast cell cytokine production(GO:0032763) |
| 0.4 |
1.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
1.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.4 |
4.3 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.4 |
1.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.4 |
1.2 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.4 |
0.8 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.4 |
10.3 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.4 |
3.0 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 |
1.5 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.4 |
0.8 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.4 |
0.8 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.4 |
0.4 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.4 |
1.9 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.4 |
0.7 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.4 |
1.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.4 |
11.2 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.4 |
1.5 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.4 |
5.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.4 |
3.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.4 |
3.6 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 |
0.7 |
GO:0035793 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.4 |
0.7 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.4 |
2.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.4 |
0.4 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.4 |
1.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.4 |
5.4 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.4 |
1.8 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.4 |
2.1 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.4 |
1.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.4 |
1.1 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.4 |
0.7 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.4 |
3.9 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.4 |
0.7 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.3 |
1.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
3.5 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.3 |
2.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.3 |
1.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
1.4 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.3 |
4.5 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.3 |
1.0 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.3 |
1.7 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.3 |
0.3 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.3 |
0.3 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.3 |
1.7 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
2.1 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.3 |
1.0 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.3 |
0.3 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.3 |
0.7 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 |
2.0 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.3 |
1.0 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.3 |
0.7 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.3 |
2.0 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.3 |
1.7 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.3 |
2.3 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.3 |
1.3 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.3 |
1.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
1.0 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.3 |
1.3 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.3 |
3.5 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.3 |
1.0 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.3 |
0.3 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.3 |
1.0 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.3 |
0.6 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 |
1.0 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 |
7.5 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.3 |
0.6 |
GO:0051103 |
DNA ligation(GO:0006266) DNA ligation involved in DNA repair(GO:0051103) |
| 0.3 |
0.3 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.3 |
1.2 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.3 |
1.2 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.3 |
0.3 |
GO:0060592 |
mammary gland formation(GO:0060592) |
| 0.3 |
1.2 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.3 |
0.6 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.3 |
0.6 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.3 |
1.5 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 |
1.2 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.3 |
3.0 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.3 |
0.9 |
GO:0046959 |
habituation(GO:0046959) |
| 0.3 |
0.9 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.3 |
1.8 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
1.2 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.3 |
1.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
1.5 |
GO:0061620 |
glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.3 |
1.2 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.3 |
3.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 |
0.6 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.3 |
4.4 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.3 |
2.1 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 |
0.9 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.3 |
1.5 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 |
1.5 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.3 |
0.9 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 |
0.6 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
1.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
0.6 |
GO:1903977 |
positive regulation of Schwann cell migration(GO:1900149) positive regulation of glial cell migration(GO:1903977) |
| 0.3 |
1.7 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.3 |
1.4 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
1.7 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.3 |
0.6 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.3 |
0.6 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.3 |
1.4 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.3 |
7.0 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.3 |
0.8 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.3 |
1.1 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.3 |
0.8 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.3 |
1.1 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.3 |
0.3 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.3 |
2.2 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.3 |
0.5 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.3 |
1.6 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.3 |
1.4 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
2.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.3 |
5.9 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.3 |
0.5 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 |
0.8 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 0.3 |
0.8 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.3 |
1.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.3 |
1.8 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 |
0.8 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.3 |
0.5 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 |
1.3 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.3 |
0.5 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.3 |
4.9 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.3 |
3.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 |
1.0 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.3 |
0.5 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.3 |
1.3 |
GO:0044088 |
regulation of vacuole organization(GO:0044088) |
| 0.3 |
3.5 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.3 |
1.0 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.3 |
1.8 |
GO:1900116 |
sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.3 |
0.5 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.3 |
2.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.3 |
1.0 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 |
1.2 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.2 |
0.5 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.2 |
0.7 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
1.2 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 |
5.7 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.2 |
1.5 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 |
0.7 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
1.5 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
7.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.2 |
3.1 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.2 |
1.0 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 |
1.0 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.2 |
0.2 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.2 |
0.5 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.2 |
1.2 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.2 |
2.4 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.2 |
1.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
1.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
1.4 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
0.2 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.2 |
0.7 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 |
1.8 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
1.1 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.2 |
0.9 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.2 |
1.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
1.8 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.2 |
0.7 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
0.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
0.9 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 |
2.3 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.2 |
4.5 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.2 |
1.6 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
0.9 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
0.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
0.2 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 |
0.2 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.2 |
1.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
0.9 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.2 |
0.7 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.2 |
0.2 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.2 |
0.4 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.2 |
1.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
0.7 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
0.7 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.2 |
1.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
2.0 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
1.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.2 |
0.7 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
1.1 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.2 |
1.5 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.2 |
0.2 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 |
0.6 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 |
0.6 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.2 |
0.6 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 |
2.1 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 |
0.4 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 |
0.6 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
0.4 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.2 |
0.6 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
0.8 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
1.2 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.2 |
1.0 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
0.8 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.2 |
0.8 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.2 |
0.8 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.2 |
1.0 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.2 |
3.4 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.2 |
0.4 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.2 |
0.6 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.2 |
6.2 |
GO:0010737 |
protein kinase A signaling(GO:0010737) |
| 0.2 |
0.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
1.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
1.2 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
0.8 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.2 |
1.4 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.2 |
0.4 |
GO:0048241 |
epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.2 |
0.6 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
3.1 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.2 |
1.0 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.2 |
0.2 |
GO:1901077 |
relaxation of cardiac muscle(GO:0055119) regulation of relaxation of muscle(GO:1901077) regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 |
7.2 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.2 |
1.2 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.2 |
3.5 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.2 |
1.0 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.2 |
1.9 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.2 |
0.2 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.2 |
1.0 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
1.3 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.2 |
4.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.2 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 |
0.2 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.2 |
0.8 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
0.2 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.2 |
1.7 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.2 |
0.2 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.2 |
1.5 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 |
0.2 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.2 |
1.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
1.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
0.9 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.2 |
0.4 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.2 |
1.1 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 |
0.4 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.2 |
1.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
0.5 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.2 |
0.9 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 |
0.5 |
GO:0010954 |
positive regulation of protein processing(GO:0010954) |
| 0.2 |
0.5 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.2 |
2.0 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 |
1.4 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.2 |
1.6 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
0.9 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.2 |
0.9 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 |
0.5 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 |
0.5 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
0.7 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.2 |
0.7 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.2 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.7 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
0.8 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.2 |
1.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
1.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
0.2 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
1.5 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.2 |
1.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.2 |
0.8 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
2.2 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.2 |
0.2 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 |
2.0 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.2 |
4.4 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.2 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
0.8 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 |
0.8 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.2 |
1.9 |
GO:0051446 |
positive regulation of meiotic cell cycle(GO:0051446) |
| 0.2 |
1.6 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.2 |
0.6 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.2 |
0.3 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.2 |
0.6 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
0.5 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.2 |
4.0 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.2 |
0.9 |
GO:0030216 |
keratinocyte differentiation(GO:0030216) |
| 0.2 |
2.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
0.8 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 |
0.3 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.2 |
0.3 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.2 |
0.2 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.2 |
1.4 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.2 |
0.9 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
1.8 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
4.6 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.2 |
0.6 |
GO:0045655 |
regulation of monocyte differentiation(GO:0045655) |
| 0.2 |
1.2 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 |
0.8 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
0.5 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
2.1 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.2 |
2.0 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.9 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
| 0.1 |
1.5 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.3 |
GO:0071224 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) cellular response to peptidoglycan(GO:0071224) |
| 0.1 |
1.2 |
GO:0061140 |
lung secretory cell differentiation(GO:0061140) |
| 0.1 |
0.4 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.9 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
0.6 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
1.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
1.0 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.1 |
0.1 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.1 |
0.4 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
2.4 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.9 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.7 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.6 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.7 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.7 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.3 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.3 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.3 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.1 |
0.7 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.3 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.4 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 |
0.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
1.5 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.5 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
2.1 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 |
0.4 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.3 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.1 |
0.7 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.5 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
0.4 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
0.4 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.1 |
0.7 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
1.6 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
0.1 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.1 |
1.7 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.1 |
0.4 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.4 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
5.1 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
2.6 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.1 |
0.1 |
GO:1903337 |
positive regulation of vacuolar transport(GO:1903337) |
| 0.1 |
0.5 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.1 |
0.9 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
3.0 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
1.5 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.4 |
GO:0030421 |
defecation(GO:0030421) |
| 0.1 |
0.3 |
GO:0061197 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
| 0.1 |
0.5 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
1.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
2.3 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
7.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
0.5 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.1 |
1.8 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.1 |
0.3 |
GO:0030449 |
regulation of complement activation(GO:0030449) negative regulation of complement activation(GO:0045916) regulation of protein activation cascade(GO:2000257) negative regulation of protein activation cascade(GO:2000258) |
| 0.1 |
0.1 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 |
1.5 |
GO:0060841 |
venous blood vessel development(GO:0060841) |
| 0.1 |
0.4 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.1 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.1 |
2.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.4 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 |
1.1 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
1.9 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.1 |
0.9 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
0.5 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.2 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.1 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.2 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.1 |
6.0 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
1.8 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.5 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.9 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.1 |
0.6 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.7 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.1 |
0.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.5 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.1 |
2.0 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.4 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.2 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
1.0 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
0.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.1 |
0.8 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.4 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
0.5 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
1.1 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.1 |
0.8 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 |
0.9 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.1 |
1.3 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
0.2 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.3 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.5 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.2 |
GO:0042268 |
regulation of cytolysis(GO:0042268) negative regulation of cytolysis(GO:0045918) |
| 0.1 |
0.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.8 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
1.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.3 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.1 |
0.1 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.1 |
1.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
0.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.6 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.3 |
GO:0034310 |
terpenoid catabolic process(GO:0016115) polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) primary alcohol catabolic process(GO:0034310) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.9 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
2.1 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
1.3 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
0.4 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
0.8 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.1 |
GO:0071220 |
response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.1 |
0.6 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) |
| 0.1 |
0.8 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.3 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.4 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.4 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.7 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.2 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.3 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.1 |
0.6 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 |
0.3 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.5 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
1.0 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
1.6 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.1 |
2.2 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
0.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.5 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.3 |
GO:0051934 |
dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
0.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
1.6 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
0.1 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
1.0 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.1 |
1.6 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.4 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.4 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.6 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
1.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
2.7 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.1 |
1.9 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.2 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
1.5 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.2 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.4 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.3 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
2.7 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.1 |
0.6 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
0.3 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
0.3 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.6 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
3.3 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.2 |
GO:0051654 |
establishment of mitochondrion localization(GO:0051654) |
| 0.1 |
0.2 |
GO:0032691 |
negative regulation of interleukin-1 beta production(GO:0032691) negative regulation of interleukin-1 production(GO:0032692) |
| 0.1 |
1.0 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
0.3 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.2 |
GO:2000152 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.9 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 |
0.4 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.3 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.1 |
0.4 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
1.0 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.1 |
0.5 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.4 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
2.7 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.6 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.9 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) |
| 0.1 |
0.2 |
GO:0051709 |
regulation of killing of cells of other organism(GO:0051709) |
| 0.1 |
0.3 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.7 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
0.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) glyoxylate metabolic process(GO:0046487) |
| 0.1 |
1.7 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.1 |
0.7 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
1.5 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
1.4 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 |
0.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.4 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
0.7 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.1 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
2.5 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.3 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
1.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.4 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 |
0.8 |
GO:0055013 |
cardiac muscle cell development(GO:0055013) |
| 0.1 |
0.1 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.1 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.1 |
0.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.2 |
GO:0045683 |
negative regulation of epidermis development(GO:0045683) |
| 0.1 |
0.6 |
GO:0035336 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
| 0.1 |
0.4 |
GO:1904666 |
regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
0.7 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 |
0.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.5 |
GO:1904037 |
positive regulation of epithelial cell apoptotic process(GO:1904037) |
| 0.1 |
1.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.4 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
1.9 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.1 |
2.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
1.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.9 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
1.0 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.1 |
0.8 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.1 |
0.5 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.8 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
0.2 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.2 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.6 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.1 |
0.2 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.1 |
0.9 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.4 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.2 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
0.1 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.5 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.9 |
GO:0044819 |
mitotic G1/S transition checkpoint(GO:0044819) |
| 0.1 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
1.5 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.8 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.1 |
1.2 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.2 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
1.4 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.4 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.5 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.1 |
1.3 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.2 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.1 |
0.2 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.1 |
0.4 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.4 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.1 |
0.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.6 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.1 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.1 |
0.2 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.1 |
0.4 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.1 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.1 |
0.1 |
GO:0060916 |
mesenchymal cell proliferation involved in lung development(GO:0060916) |
| 0.1 |
2.5 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.6 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
2.0 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.6 |
GO:2000758 |
positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.1 |
0.2 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.1 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.5 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
6.0 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.1 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.2 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.1 |
0.4 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.3 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.1 |
1.3 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.2 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 |
0.6 |
GO:0032402 |
melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.1 |
0.2 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 |
0.3 |
GO:1903299 |
regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 0.1 |
2.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
2.2 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 |
0.2 |
GO:0035356 |
negative regulation of mitochondrial membrane potential(GO:0010917) cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.2 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 |
0.7 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.3 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.1 |
0.4 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.1 |
1.1 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 |
0.1 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
0.8 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
0.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.2 |
GO:0019614 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.1 |
0.1 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.1 |
0.7 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 |
0.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.3 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.9 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
0.5 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.3 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
2.5 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 |
0.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.2 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.1 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.4 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.1 |
0.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.4 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.5 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
0.1 |
GO:0038089 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
1.6 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
5.1 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.1 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.3 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.2 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.1 |
0.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
2.7 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
2.3 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
0.1 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.1 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.1 |
1.4 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.3 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
1.0 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.3 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.7 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.3 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.1 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
1.2 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.4 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.8 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.2 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
0.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.0 |
0.1 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.3 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.3 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.0 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.8 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.0 |
0.1 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.0 |
0.2 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.0 |
0.8 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 |
0.3 |
GO:0002548 |
monocyte chemotaxis(GO:0002548) |
| 0.0 |
0.5 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.8 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.1 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.0 |
0.0 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.0 |
0.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:1901727 |
regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.3 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
2.1 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
2.5 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.3 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.0 |
0.1 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.0 |
0.2 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.2 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.0 |
0.1 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
0.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
1.6 |
GO:0007613 |
memory(GO:0007613) |
| 0.0 |
0.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.0 |
0.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.2 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.3 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 |
0.3 |
GO:1900408 |
negative regulation of cellular response to oxidative stress(GO:1900408) negative regulation of response to oxidative stress(GO:1902883) |
| 0.0 |
0.1 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.2 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.1 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.2 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.0 |
0.1 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.3 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.2 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.0 |
0.1 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.1 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.2 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.0 |
0.1 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.2 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.3 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.0 |
0.1 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.0 |
0.4 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.1 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.2 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.0 |
0.2 |
GO:0009112 |
nucleobase metabolic process(GO:0009112) |
| 0.0 |
0.2 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.0 |
1.0 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.1 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.0 |
0.4 |
GO:0044773 |
mitotic DNA damage checkpoint(GO:0044773) |
| 0.0 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
1.0 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.0 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.0 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.0 |
0.2 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.0 |
0.3 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
0.0 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.0 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.1 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.2 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 |
0.1 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.0 |
0.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
1.5 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.2 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
1.6 |
GO:0010466 |
negative regulation of peptidase activity(GO:0010466) |
| 0.0 |
0.4 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.0 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.0 |
0.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.2 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.0 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.0 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.2 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.4 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) late viral transcription(GO:0019086) |
| 0.0 |
0.0 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.1 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.1 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.0 |
0.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.3 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.0 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.0 |
0.1 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.0 |
0.1 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.1 |
GO:2000058 |
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
| 0.0 |
0.1 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.6 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 |
0.0 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.1 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.0 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.2 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
1.0 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.3 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.0 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.4 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.0 |
0.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 |
0.1 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.0 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.1 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 |
0.0 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 0.0 |
0.1 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.1 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.0 |
0.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
